Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Flow Nasal Therapy Versus Conventional Oxygen Therapy in Patients With COVID-19: A Randomized Controlled Trial (The COVID-HIGH Trial)

NCT04655638 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo as lead sponsor.

NCT NCT04655638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Flow Nasal Therapy Versus Conventional Oxygen Therapy in Patients With COVID-19: A Randomized Controlled Trial (The COVID-HIGH Trial)
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Phase
Not applicable
Overall status
Completed
Start date
February 10, 2021
Completion date
October 25, 2021
Enrollment
364 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, covid19